Correlation of tumor gene expression profile and gleason score (GS) in patients (pts) with metastatic prostate cancer.

Authors

null

Nicolas Sayegh

Hunstman Cancer Institute at the University of Utah, Salt Lake City, UT

Nicolas Sayegh , Nishita Tripathi , Beverly Chigarira , Yeonjung Jo , Vinay Mathew Thomas , Roberto Nussenzveig , Kamal Kant Kant Sahu , Haoran Li , Georges Gebrael , Clara Tandar , Divyam Goel , Nityam Rathi , Benjamin L. Maughan , Umang Swami , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 235)

DOI

10.1200/JCO.2023.41.6_suppl.235

Abstract #

235

Poster Bd #

H19

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Association of adaptive immunity/inflammatory genes with survival in prostate cancer.

Association of adaptive immunity/inflammatory genes with survival in prostate cancer.

First Author: Austin Hopper

Poster

2023 ASCO Genitourinary Cancers Symposium

Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).

Correlation of age and the tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa).

First Author: Kamal Kant Kant Sahu

First Author: Yi Sun

Poster

2016 Genitourinary Cancers Symposium

Association of chronic baseline prostate inflammation with lower tumor grade in men with prostate cancer on repeat biopsy.

Association of chronic baseline prostate inflammation with lower tumor grade in men with prostate cancer on repeat biopsy.

First Author: Daniel M. Moreira